CancerNetwork Members: Login | Register
Become a fan on  Facebook  Add us on  Google Plus Follow us on  Twitter Join us on LinkedIn Sign up for our Newsletters Subscribe to our RSS Feed

 

CancerNetwork SearchMedica Medline Drugs

Powered by SearchMedica

 
PUBLICATIONS
NEWS
PODCASTS
TOPICS
BLOGS
NURSES
PATIENTS
JOBS
CONFERENCES
CME
SUPPLEMENTS
 

Home » NEWS

Oncology NEWS International. Vol. 5 No. 11
 

Antibiotic Monitoring Programs Can Avert Potential Errors in Prescribing

November 1, 1996

NEW ORLEANS--Monitoring programs in which hospital pharmacists double-check physicians' orders for antibiotics are proving effective in averting potential problems of safety or efficacy, researchers reported at the 36th Inter-science Conference on Antimicrobials and Chemotherapy (ICAAC).

At the University of California Medical Center, San Francisco, hospital pharmacists intervened a total of 3,344 times over a 2-year period; these interventions represent 5% of the total number of antibiotic prescriptions during that time.

Of these interventions, 858 were classified as "high level," including 471 to avoid potential drug toxicity and 387 to enhance efficacy, reported B. Joseph Guglielmo, PharmD, professor of clinical pharmacy.

"Antimicrobial monitoring programs are common at academic medical centers, but they are not as well established throughout the hospital industry, which I think is unfortunate," he commented. "In addition to enhancing safety, prescription monitoring also saves money because better treatment circumvents complications."

In the San Francisco monitoring system, pharmacists and consulting infectious disease specialists probably prevented 31 to 68 cases of kidney toxicity and 13 to 40 cases of hearing damage by intervening to recommend substitution or reduction of an aminoglycoside dose, Dr. Guglielmo said.

A study from the Albany Medical Center Hospital, NY, showed that pharmacists there also averted many problems by reviewing antimicrobial prescriptions.

Laurie Briceland, PharmD, and Daniel Stein, MD, reported that, over a 20-month period, hospital pharmacists detected and avoided 1,048 potential errors in antibiotic prescriptions in this large teaching institution, where most prescriptions are written by house staff.

Of these errors, 16% were classified as having the potential to produce "severe or life-threatening" consequences, such as anaphylactic reactions; 14% were judged to have the potential for "serious" consequences; and 70% for "significant" consequences.

Dosing errors were most frequent (62%), followed by ordering antibiotics to which the patient was known to be allergic (20%). Most errors occurred for parenteral antibiotics. Beta-lactams were the most frequently implicated (46%), followed by aminoglycosides, macrolides, and antifungals, Dr. Briceland said.

Consider Specific Conditions

Most errors occurred because physicians did not account for some specific condition (51%), such as impaired renal function, she added.

While averting prescription errors was the focus of the first two studies, a third study looked at whether hospitalized patients actually get their medications as prescribed.

Blake E. Max, PharmD, followed 29 patients on an HIV ward at Cook County Hospital, Chicago, for 18 days. He calculated a medication error rate of 20% and found that some patients never received their prescribed medications.

Dr. Max reviewed nursing medication administration records daily, and collected data on oral and IV medications delivered to the ward and returned to the pharmacy. Errors included dose not given, unordered dose given, and extra doses given.

The error rate per patient ranged from 3% to 37%. Errors were most likely to occur in patients receiving the greatest number of medications, he said.

 

Join the Conversation

Want to join the conversation? If you're a healthcare professional, we'd like to hear your comments. Just sign in or register today to become part of our growing, online community.






 
TOPIC INDEX

Cancer Types

 
  • Breast
  • Breast (HER2+)
  • Breast (Triple-Negative)
  • CML
  • Colorectal
  • Gastrointestinal
  • GIST
  • Genitourinary
  • Gynecologic
  • Head & Neck
  • Hematology
  • Kidney (Renal Cell)
  • Leukemia
  • Lung
  • Lymphoma
  • Melanoma
  • Multiple Myeloma
  • Ovarian
  • Prostate
  • Sarcoma

Supportive Care

More Topics

  • Bone Metastases
  • End-of-Life Care
  • Palliative Care
  • Ethics in Oncology
  • Practice Management
  • Practice & Policy


All Topics 


 
FROM PHYSICIANS PRACTICE
Primary Care Can't Thrive Without Nurse Practitioners
Courtney H. Lyder, ND,  May 17, 2013
With a projected shortfall of primary-care physicians, it's time for alternate solutions to patient care. Nurse practitioners are one logical remedy.
VWhat Physicians Can Learn from the Allscripts EHR Lawsuit
Marisa Torrieri,  May 16, 2013
Lawsuit prompts question: What should physicians do to ensure they end up with a great EHR instead of buyer’s remorse?
Eight Ways ICD-9 Will Still Matter to Medical Practices
Brenda Edwards, CPC,  May 15, 2013
What should your medical practice do with your ICD-9-CM book after October 1, 2014? Keep it.
Seven Ways Technology Can Speed Up Patient Collections
Cheyenne Brinson,  May 15, 2013
Failing to adopt widely available billing and collections technology can cost medical practices big. Here's how to do it right.
Four Reasons Private Medical Practice is Becoming Extinct
Carol Stryker,  May 15, 2013
It’s becoming increasingly difficult for private medical practices to thrive. Here’s what’s driving the trend toward consolidation.
 

 

 
MOST POPULAR
  • Most Popular
  • Most Emailed
  • Most Recent
  • Skin Lesions
  • Colorectal Lesions
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Slide Show: Squamous Cell Carcinoma of the Head and Neck
  • “This Is My Last Day on Earth”
  • Dermatologic Adverse Events Associated With Targeted Therapies
  • Recurrent Epithelial Ovarian Cancer: An Update on Treatment
  • ONS: Understanding Spirituality and How It Can Be Used to Help Patients
  • Colorectal Lesions
  • New AUA Guidelines for Prostate Cancer Screening
  • 50 Shades of Pink—And Why It Helps to Know the Difference
  • Genomics Studies Identify Testicular Cancer Risk Variants
  • Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
  • FDA Approves Erlotinib (Tarceva) as First-Line Lung Cancer Therapy for Certain Patients
Click here to subscribe to our newsletter


CancerNetwork on Facebook


CancerNetwork | ConsultantLive | Diagnostic Imaging | Musculoskeletal Network | OBGYN.net | PediatricsConsultantLive |
Physicians Practice | Psychiatric Times | SearchMedica | Medical Resources

© 1996 - 2013 UBM Medica LLC, a UBM company
Privacy Statement - Terms of Service - Advertising Information - Editorial Policy Statement - UBM Medica Network Privacy Policy